Compare Stocks: TXG, PACB, ILMN, and MTD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ILMN Illumina	$238.82 -0.3%	$205.60	$88.00 ▼ $250.06	$36.18B	1.46	3.52 million shs	3.16 million shs
MTD Mettler-Toledo International	$1,435.52 +3.1%	$1,373.52	$1,023.05 ▼ $1,525.17	$27.90B	1.22	189,998 shs	167,641 shs
PACB Pacific Biosciences of California	$1.36 -0.7%	$1.34	$1.07 ▼ $2.73	$425.84M	2.31	5.54 million shs	6.13 million shs
TXG 10x Genomics	$79.10 +3.3%	$57.07	$11.16 ▼ $80.11	$9.98B	2.08	2.62 million shs	2.43 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ILMN Illumina	0.00%	+16.07%	+9.22%	+48.48%	+133.21%
MTD Mettler-Toledo International	0.00%	+7.67%	-0.02%	+19.76%	+10.15%
PACB Pacific Biosciences of California	0.00%	+5.38%	+1.48%	+3.79%	+7.87%
TXG 10x Genomics	0.00%	+11.68%	+17.63%	+132.54%	+487.42%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ILMN Illumina	$238.82 -0.3%	$205.60	$88.00 ▼ $250.06	$36.18B	1.46	3.52 million shs	3.16 million shs
MTD Mettler-Toledo International	$1,435.52 +3.1%	$1,373.52	$1,023.05 ▼ $1,525.17	$27.90B	1.22	189,998 shs	167,641 shs
PACB Pacific Biosciences of California	$1.36 -0.7%	$1.34	$1.07 ▼ $2.73	$425.84M	2.31	5.54 million shs	6.13 million shs
TXG 10x Genomics	$79.10 +3.3%	$57.07	$11.16 ▼ $80.11	$9.98B	2.08	2.62 million shs	2.43 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ILMN Illumina	0.00%	+16.07%	+9.22%	+48.48%	+133.21%
MTD Mettler-Toledo International	0.00%	+7.67%	-0.02%	+19.76%	+10.15%
PACB Pacific Biosciences of California	0.00%	+5.38%	+1.48%	+3.79%	+7.87%
TXG 10x Genomics	0.00%	+11.68%	+17.63%	+132.54%	+487.42%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ILMN Illumina	2.44	Hold	$199.13	-16.62% Downside
MTD Mettler-Toledo International	2.31	Hold	$1,446.36	0.75% Upside
PACB Pacific Biosciences of California	1.83	Reduce	$1.71	25.92% Upside
TXG 10x Genomics	2.24	Hold	$44.00	-44.37% Downside

Current Analyst Ratings Breakdown

Latest TXG, PACB, ILMN, and MTD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/10/2026	PACB Pacific Biosciences of California	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/9/2026	ILMN Illumina	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$135.00 ➝ $260.00
9/9/2026	MTD Mettler-Toledo International	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy ➝ Neutral	$1,650.00 ➝ $1,460.00
9/9/2026	PACB Pacific Biosciences of California	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$1.50 ➝ $1.35
9/9/2026	TXG 10x Genomics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$20.00 ➝ $68.00
9/8/2026	MTD Mettler-Toledo International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/3/2026	ILMN Illumina	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$180.00 ➝ $235.00
9/2/2026	MTD Mettler-Toledo International	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell	$1,200.00
9/1/2026	TXG 10x Genomics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$70.00
9/1/2026	ILMN Illumina	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/1/2026	MTD Mettler-Toledo International	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$1,515.00

(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ILMN Illumina	$4.34B	8.30	$6.69 per share	35.69	$17.82 per share	13.40
MTD Mettler-Toledo International	$4.03B	7.14	$51.18 per share	28.05	($1.16) per share	-1,237.52
PACB Pacific Biosciences of California	$160.01M	2.64	$0.78 per share	1.74	$0.02 per share	68.00
TXG 10x Genomics	$642.82M	16.03	N/A	N/A	$6.24 per share	12.68

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ILMN Illumina	$850M	$5.36	46.53	39.15	3.40	18.36%	29.84%	12.17%	10/29/2026 (Estimated)
MTD Mettler-Toledo International	$869.19M	$44.43	31.02	27.46	2.79	21.91%	-1,212.14%	25.11%	11/5/2026 (Estimated)
PACB Pacific Biosciences of California	-$546.38M	-$0.43	N/A	N/A	N/A	-82.49%	-5,752.12%	-19.52%	11/3/2026 (Estimated)
TXG 10x Genomics	-$43.54M	-$0.59	N/A	N/A	N/A	-12.18%	-9.33%	-7.30%	11/5/2026 (Estimated)

Latest TXG, PACB, ILMN, and MTD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	TXG 10x Genomics	-$0.2431	-$0.14	+$0.1031	-$0.14	$146.67 million	$151.04 million
8/3/2026	Q2 2026	PACB Pacific Biosciences of California	-$0.1280	-$0.14	-$0.0120	-$0.14	$42.90 million	$39.01 million
7/31/2026	Q2 2026	MTD Mettler-Toledo International	$10.78	$11.46	+$0.68	$11.55	$1.03 billion	$1.03 billion
7/30/2026	Q2 2026	ILMN Illumina	$1.23	$1.31	+$0.08	$1.35	$1.13 billion	$1.16 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
MTD Mettler-Toledo International	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ILMN Illumina	0.53	1.80	1.40
MTD Mettler-Toledo International	159.45	1.12	0.78
PACB Pacific Biosciences of California	N/A	4.92	4.03
TXG 10x Genomics	N/A	5.69	5.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ILMN Illumina	89.42%
MTD Mettler-Toledo International	95.07%
PACB Pacific Biosciences of California	N/A
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
ILMN Illumina	2.90%
MTD Mettler-Toledo International	0.71%
PACB Pacific Biosciences of California	3.70%
TXG 10x Genomics	8.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ILMN Illumina	8,650	151.00 million	146.62 million	Optionable
MTD Mettler-Toledo International	18,100	20.04 million	19.90 million	Optionable
PACB Pacific Biosciences of California	485	310.83 million	299.33 million	Optionable
TXG 10x Genomics	1,178	130.29 million	118.77 million	Optionable

TXG, PACB, ILMN, and MTD Headlines

Recent News About These Companies

10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors

24 minutes ago | gurufocus.com

10x Genomics (NASDAQ:TXG) Hits New 52-Week High - Here's What Happened

September 21 at 11:59 AM | marketbeat.com

Deutsche Bank Adjusts 10x Genomics Price Target to $70 From $40, Maintains Hold Rating

September 21 at 9:04 AM | marketscreener.comM

10x Genomics (TXG) Stock May Look Pricey As Oncology AI News Lands

September 19 at 12:58 PM | finance.yahoo.com

Tidal Investments LLC Makes New $1.28 Million Investment in 10x Genomics $TXG

September 19 at 3:37 AM | marketbeat.com

Corient Private Wealth LP Has $6.57 Million Stake in 10x Genomics $TXG

September 18 at 3:12 AM | marketbeat.com

10x Genomics (NASDAQ:TXG) Given Consensus Rating of "Hold" by Brokerages

September 17, 2026 | americanbankingnews.com

10x Genomics (NASDAQ:TXG) Receives Average Recommendation of "Hold" from Brokerages

September 17, 2026 | marketbeat.com

10x Genomics Inc Class A

September 16, 2026 | cnn.com

10x Genomics consensus price target raised 10.70% to $53.33

September 15, 2026 | msn.com

Engineers Gate Manager LP Sells 33,284 Shares of 10x Genomics $TXG

September 15, 2026 | marketbeat.com

Squarepoint Ops LLC Purchases Shares of 53,966 10x Genomics $TXG

September 15, 2026 | marketbeat.com

10x Genomics (NASDAQ:TXG) Hits New 1-Year High - Time to Buy?

September 15, 2026 | marketbeat.com

10x Genomics Stock (TXG) Opinions on Insider Selling and Atera Platform

September 12, 2026 | quiverquant.comQ

Adam Taich Sells 46,388 Shares of 10x Genomics (NASDAQ:TXG) Stock

September 12, 2026 | insidertrades.com

Insider Selling: 10x Genomics (NASDAQ:TXG) CFO Sells $2,995,273.16 in Stock

September 11, 2026 | marketbeat.com

UBS Sticks to Its Hold Rating for 10x Genomics (TXG)

September 11, 2026 | theglobeandmail.com

Moderna, 10x Genomics, Oscar Health, and Novavax shares are soaring, what you need to know

September 11, 2026 | msn.com

VIRGINIA RETIREMENT SYSTEMS ET Al Invests $2.38 Million in 10x Genomics $TXG

September 11, 2026 | marketbeat.com

UBS Group Boosts 10x Genomics (NASDAQ:TXG) Price Target to $68.00

September 11, 2026 | americanbankingnews.com

Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research

September 10, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, ILMN, and MTD Company Descriptions

Illumina NASDAQ:ILMN

$238.82 -0.80 (-0.33%)

As of 04:00 PM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Mettler-Toledo International NYSE:MTD

$1,435.52 +43.20 (+3.10%)

As of 03:58 PM Eastern

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Pacific Biosciences of California NASDAQ:PACB

$1.36 -0.01 (-0.73%)

As of 04:00 PM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

10x Genomics NASDAQ:TXG

$79.10 +2.50 (+3.26%)

As of 04:00 PM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TXG, PACB, ILMN, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TXG, PACB, ILMN, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TXG, PACB, ILMN, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, ILMN, and MTD Company Descriptions

Illumina NASDAQ:ILMN

Mettler-Toledo International NYSE:MTD

Pacific Biosciences of California NASDAQ:PACB

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TXG, PACB, ILMN, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TXG, PACB, ILMN, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TXG, PACB, ILMN, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, ILMN, and MTD Company Descriptions

Illumina NASDAQ:ILMN

Mettler-Toledo International NYSE:MTD

Pacific Biosciences of California NASDAQ:PACB

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools